The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AMBIT BIOSCIENCES CORP | COM | 02318X100 | 0 | 24 | SH | SOLE | 24 | 0 | 0 | ||
AMBIT BIOSCIENCES CORP | COM | 02318X100 | 0 | 22 | SH | OTR | 1 | 0 | 22 | 0 | |
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 13,157 | 182,300 | SH | SOLE | 182,300 | 0 | 0 | ||
CORSICANTO LTD | NOTE 3.50% 1/15/32 | 220480AC1 | 2,762 | 2,500,000 | PRN | SOLE | 2,500,000 | 0 | 0 | ||
DENDREON CORP | NOTE 2.875% 1/15/16 | 24823QAC1 | 16,191 | 26,515,000 | PRN | SOLE | 26,515,000 | 0 | 0 | ||
DENDREON CORP | COM | 24823Q107 | 233 | 79,600 | SH | OTR | 1 | 0 | 79,600 | 0 | |
DEPOMED INC | COM | 249908104 | 6,244 | 835,931 | SH | SOLE | 835,931 | 0 | 0 | ||
ENDOCYTE INC | COM | 29269A102 | 6,209 | 465,763 | SH | SOLE | 465,763 | 0 | 0 | ||
INTERMUNE INC | NOTE 2.50% 9/15/18 | 45884XAE3 | 15,263 | 17,000,000 | PRN | SOLE | 17,000,000 | 0 | 0 | ||
MANNKIND CORP | NOTE 3.750% 12/15/13 | 56400PAA0 | 17,110 | 17,144,000 | PRN | SOLE | 17,144,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 17,898 | 1,181,400 | SH | SOLE | 1,181,400 | 0 | 0 | ||
ONCOGENEX PHARMACEUTICALS INC | COM | 68230A106 | 8,650 | 933,100 | SH | SOLE | 933,100 | 0 | 0 | ||
OPKO HEALTH INC | NOTE 3.0% 2/1/33 | 68375NAA1 | 30,939 | 25,000,000 | PRN | SOLE | 25,000,000 | 0 | 0 | ||
PDL BIOPHARMA INC | NOTE 2.875% 2/15/15 | 69329YAE4 | 37,556 | 25,974,000 | PRN | SOLE | 25,974,000 | 0 | 0 | ||
SALIX PHARMACEUTICALS INC | COM | 795435106 | 20,064 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
SAVIENT PHARMACEUTICALS INC | NOTE 4.750% 2/1/18 | 80517QAA8 | 7,314 | 30,476,000 | PRN | SOLE | 30,476,000 | 0 | 0 | ||
SOPHIRIS BIO INC | COM | 83578Q209 | 2,340 | 500,000 | SH | SOLE | 500,000 | 0 | 0 |